Xconomy’s Digital Events →
Greg Verdine is the president of FogPharma and LifeMine Therapeutics
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.